Press Releases
Nycomed’s novel COPD therapy roflumilast receives FDA approval
Nycomed’s US partner Forest Laboratories, Inc.announced that DalirespTM (roflumilast) was approved by the US Food and Drug Administration (FDA) as a treatment to reduce...
Press Releases
PharmaDiagnostics appoints director of assay development
PharmaDiagnostics NV, a company developing and marketing a broadly-enabling, label-free screening technology that uniquely does not require specialized instrumentation, announces today the appointment of...
Clinical Trials
Infinity Initiates Phase 2 Trial of IPI-926 in Patients With Chondrosarcoma
Infinity Pharmaceuticals, Inc. announced the initiation of a randomized, double-blind Phase 2 clinical trial to evaluate the safety and efficacy of IPI-926 compared to...
Drug Research
Lycera Announces Research Collaboration with Merck
Lycera Corporation, a biopharmaceutical company pioneering innovative approaches to developing novel oral medicines to treat autoimmune diseases, announced that it has entered into an...
Clinical Trials
NovaBay Pharmaceuticals Initiates Phase 2 Clinical Trial for the Treatment of Urinary Catheter
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing its first-in-class, anti-infective Aganocide compounds for the local non-systemic treatment and prevention of antibiotic-resistant infections,...
Press Releases
Patent plethora in 2010 breaks record for Biocitech technology park residents
Biocitech SAS, the Paris life science technology park, today announced that its 25 resident companies applied for a bumper number of patents with a...
News
Pfizer Completes Acquisition Of King Pharmaceuticals, Inc.
Pfizer Inc. announced that it has combined operations with King Pharmaceuticals, Inc. On February 28, 2011, Pfizer completed its acquisition of King through the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read